All Cancer articles
-
BusinessJ&J proposes to pay nearly $9 billion to settle talc lawsuits
Company re-files for bankruptcy of a subsidiary in the hopes of resolving tens of thousands of claims its products caused cancer
-
Research
Biocompatible battery starves cancer cells of oxygen
Implantable self-charging battery creates hypoxic conditions to help kill tumour cells
-
Business
Pfizer to buy cancer biotech Seagen for $43 billion
Antibody-drug conjugate specialist will fill Pfizer’s cancer pipeline
-
Business
J&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information
-
Business
Judge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven
-
Business
Novartis cutting up to 8000 jobs
Restructure splits commercial activities geographically instead of by treatment area
-
Research
Light-activated cancer treatment uses tumour-targeting enzymes to cut side effects
Enzymatic activation of a photosensitive prodrug in cancerous cells shows promise in mice
-
Opinion
Carolyn Bertozzi: ‘Shooting hoops is very meditative’
The celebrated chemical biologist who dreamed of being a rock star before inventing the field of bioorthogonal chemistry
-
Research
Cancer progression and harmful bacteria tracked with next-generation sequencing
Proof-of-principle study keeps an eye on leukaemia mutations and bacterial strains in patients
-
News
Replication failures cast doubt on some cancer studies
Just 18% of experiments from top papers met all criteria for successful replication
-
Business
New J&J subsidiary to absorb talc lawsuit liabilities
Firm aims to use bankruptcy protection and a $2bn trust to resolve thousands of cancer claims
-
Research
Individual cell’s energy metabolism caught on camera for the first time
Combining machine learning with fluorescence imaging provides new insight in glycolysis and might help with development of new therapies for cancer
-
Business
Morphosys agrees to buy cancer epigenetics specialist Constellation
$1.7bn deal will be funded by selling rights to royalties on existing drugs
-
Business
US supreme court will not hear J&J talc appeal
Decision means J&J must pay $2.1 billion previously awarded to 22 women who say talc caused their ovarian cancer
-
Research
Artificial enzyme sets record as it outperforms horseradish counterpart by factor of 12
Engineered nanoparticle achieves highest efficiency of any artificial enzyme when compared with natural peroxidase
-
Business
Antibody–drug conjugates drive growth in oncology
Antibody–drug conjugates are coming of age and pharma is investing, reports Katrina Megget
-
Opinion
Why are impurity regulations different for food and drugs?
The pharmaceutical and food industries should work together more closely on genotoxic impurities
-
Research
Linking chemistry with surgery to detect cancerous cells in situ
Livia Schiavinato Eberlin explains how her team has developed a hand-held device for surgeons that analyses tissue samples on a mass spectrometer mid-operation
-
News
Wellcome Leap launches global network to tackle pressing health issues
More than 20 research institutions are part of new effort to the cut red tape hindering research
-
Research
Nanoparticle can starve aggressive breast cancer cells of vital copper
A new engineered particle depletes copper from mitochondria, killing breast cancer cells in mice
